NOMAD POWER SOLUTIONS, INC. Increase (Decrease) in Prepaid Expenses, Other
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Increase (Decrease) in Prepaid Expenses, Other of $27.66 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was -$28.58K.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was $56.24K, a 109.92% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was -$17.01K, a 133.10% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was -$26.10K.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was -$40.83K, a 153.97% decline from fiscal 2024.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was $75.65K.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$1.35K.
- NOMAD POWER SOLUTIONS, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$1.35K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$28.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $27.66K 10-Q · filed 2026-08-14 | $10.65K derived: sum of 3 quarters · filed 2026-08-14 | -$15.46K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $56.24K 10-Q · filed 2026-05-14 | $39.23K derived: sum of 2 quarters · filed 2026-05-14 | $13.13K derived: sum of 3 quarters · filed 2026-05-14 | -$11.38K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$17.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$43.12K derived: sum of 2 quarters · filed 2026-03-31 | -$67.62K derived: sum of 3 quarters · filed 2026-08-14 | -$40.83K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$26.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$50.61K derived: sum of 2 quarters · filed 2026-08-14 | -$23.81K 10-Q · filed 2025-11-12 | $27.58K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$24.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.29K 10-Q · filed 2026-08-14 | $53.69K derived: sum of 3 quarters · filed 2026-08-14 | $38.12K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $26.79K 10-Q · filed 2026-05-14 | $78.19K derived: sum of 2 quarters · filed 2026-05-14 | $62.62K derived: sum of 3 quarters · filed 2026-05-14 | $38.32K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $51.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $35.83K derived: sum of 2 quarters · filed 2026-03-31 | $11.52K derived: sum of 3 quarters · filed 2026-03-31 | $75.65K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$15.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$39.87K derived: sum of 2 quarters · filed 2025-11-12 | $24.26K 10-Q · filed 2025-11-12 | $5.45K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$24.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $39.82K 10-Q · filed 2025-08-07 | $21.01K derived: sum of 3 quarters · filed 2025-08-07 | -$709.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $64.13K 10-Q · filed 2025-05-12 | $45.32K derived: sum of 2 quarters · filed 2025-05-12 | $23.60K derived: sum of 3 quarters · filed 2025-05-12 | $17.06K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$18.81K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$40.53K derived: sum of 2 quarters · filed 2025-03-24 | -$47.07K derived: sum of 3 quarters · filed 2025-03-24 | -$1.35K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$21.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$28.26K derived: sum of 2 quarters · filed 2024-11-12 | $17.46K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$6.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $39.18K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $45.72K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.35K 10-K · filed 2024-03-19 | |||
| 2020-12-31 | -$9.29K 10-K · filed 2021-03-26 | |||
| 2019-12-31 | -$9.17K 10-K · filed 2021-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |